Tuberculosis (TB), caused by Mycobacterium tuberculosis (MTB), is a prevalent global
infectious disease and a leading cause of mortality worldwide. Currently, the only available …

Introduction The Bacillus Calmette-Guérin (BCG) vaccine, currently used against
tuberculosis (TB), exhibits inconsistent efficacy, highlighting the need for more potent TB …

Tuberculosis (TB) is a global health threat, killing approximately 1.5 million people each
year. The eradication of Mycobacterium tuberculosis, the main causative agent of TB, is …

The induction of an effective immune response is critical for the success of mRNA-based
therapeutics. Here, we developed a nanoadjuvant system compromised of Quil-A and …

Marburg virus (MARV) has been a major concern since its first outbreak in 1967. Although
the deadly BSL-4 pathogen has been reported in few individuals with sporadic outbreaks …

Chlamydia trachomatis (CT) remains a significant infectious cause of blindness and sexually
transmitted infections worldwide. The objective and novelty of this study lie in using different …

The major problem in cases of chronic hepatitis B (CHB) is the failure of the patient's
immune response to eliminate the covalently closed circular DNA (cccDNA) …

Objectives Current tuberculosis (TB) control strategies face limitations, such as low antibiotic
treatment compliance and a rise in multidrug resistance. Furthermore, the lack of a safe and …

Abstract Astrovirus MLB1 (HAstV-MLB1) is non-enveloped RNA virus that cause acute
gastroenteritis infection. Despite research progress about infection and pathogenesis of …

Background Latent tuberculosis infection (LTBI) often progresses to active tuberculosis,
necessitating the development of novel vaccine to prevent LTBI. In this study, we aimed to …